TRV GP IV, LLC Holdings

TRV GP IV, LLC is an investment fund managing more than 171.14M US dollars. The largest holdings include Tango Therapeutics, Pliant Therapeutics and Revolution Medicines. In Q3 2021 the fund bought assets of total value of 250.38M US dollars and sold assets of total value of 29.12M US dollars.

$171.13M

portfolio value

+12.54%

quarter

-61.17%

1 year

-297.52%

3 years

TRV GP IV, LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q3 2021	250376000	29120000

TRV GP IV, LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Tango Therapeutics, Inc. Portfolio share: 40.96% Portfolio value: 70.09M Avg. open price: N/A Current price: $7.94 P/L: N/A N/A Q3 2021	share	40.96%	70.09M	N/A	$7.94	N/A	N/A Q3 2021
Biotechnology Pliant Therapeutics, Inc. Portfolio share: 26.04% Portfolio value: 44.55M Avg. open price: N/A Current price: $17.83 P/L: N/A N/A Q2 2020	share	26.04%	44.55M	N/A	$17.83	N/A	N/A Q2 2020
Biotechnology Revolution Medicines, Inc. Portfolio share: 16.36% Portfolio value: 28M Avg. open price: N/A Current price: $25.53 P/L: N/A N/A Q1 2020	share	16.36%	28M	N/A	$25.53	N/A	N/A Q1 2020
Biotechnology Fulcrum Therapeutics, Inc. Portfolio share: 11.08% Portfolio value: 18.95M Avg. open price: N/A Current price: $6.75 P/L: N/A N/A Q3 2019	share	11.08%	18.95M	N/A	$6.75	N/A	N/A Q3 2019
Biotechnology Magenta Therapeutics, Inc. Portfolio share: 5.57% Portfolio value: 9.52M Avg. open price: N/A Current price: $1.33 P/L: N/A Sold -15.61% shares Q3 2021	share	5.57%	9.52M	N/A	$1.33	N/A	Sold -15.61% shares Q3 2021

Showing TOP 5 TRV GP IV's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of TRV GP IV, LLC?

The biggest position of the TRV GP IV, LLC is Tango Therapeutics, Inc. (TNGX) with 40.96% portfolio share worth of 70.1M US dollars.

Top 5 TRV GP IV's holdings represent 100% of the portfolio:

Tango Therapeutics, Inc. (TNGX) – 40.96%
Pliant Therapeutics, Inc. (PLRX) – 26.04%
Revolution Medicines, Inc. (RVMD) – 16.36%
Fulcrum Therapeutics, Inc. (FULC) – 11.08%
Magenta Therapeutics, Inc. (MGTA) – 5.57%

Who is the portfolio manager of TRV GP IV, LLC?

The portfolio manager of the TRV GP IV, LLC is .

What is the total asset value of the TRV GP IV, LLC portfolio?

TRV GP IV, LLC total asset value (portfolio value) is 171.14M US dollars.

Who is ?

is the portfolio manager of the TRV GP IV, LLC.

What is (TRV GP IV, LLC) fund performance?

TRV GP IV's quarterly performance is +12.54%, annualy -61.17%. In the past 3 years, the value of 's portfolio has decreased by -298%.

What is the TRV GP IV, LLC CIK?

TRV GP IV's Central Index Key is 0001688325 .